CYTOKINETICS, INCORPORATED Current Liabilities
CYTOKINETICS, INCORPORATED (CYTK) had Current Liabilities of $181.43 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Liabilities, Current $181.43M.
- 2026-03-31: Liabilities, Current $199.19M.
- 2025-12-31: Liabilities, Current $202.45M.
- 2025-09-30: Liabilities, Current $142.14M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $181.43M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $199.19M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $202.45M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $142.14M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $131.06M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $159.73M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $179.67M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $109.81M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $102.78M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $88.86M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $102.68M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $77.72M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $65.62M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $75.22M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $84.62M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $76.50M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $66.84M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $66.85M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $71.86M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $80.87M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $61.77M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $35.93M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $31.20M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $27.57M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $22.70M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $20.74M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $26.02M 10-K · filed 2021-02-26 | |
| 2019-09-30 | $21.52M 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $21.96M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $26.28M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $22.19M 10-K · filed 2020-03-04 | |
| 2018-09-30 | $21.49M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $27.29M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $38.55M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $32.44M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $42.36M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $31.06M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $36.80M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $33.26M 10-K · filed 2018-03-05 | |
| 2016-09-30 | $27.86M 10-Q/A · filed 2016-12-15 | $29.33M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $26.27M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $24.68M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $31.65M 10-K · filed 2017-03-06 | |
| 2015-09-30 | $30.14M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $29.11M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $25.39M 10-Q · filed 2015-05-04 | |
| 2014-12-31 | $23.86M 10-K · filed 2016-03-03 | |
| 2014-09-30 | $12.99M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $16.92M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $19.79M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $26.70M 10-K · filed 2015-03-06 | |
| 2013-09-30 | $45.01M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $34.05M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $5.82M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $7.11M 10-K · filed 2014-03-07 | |
| 2012-09-30 | $4.59M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $3.99M 10-Q · filed 2012-08-06 | |
| 2012-03-31 | $4.47M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $4.59M 10-K · filed 2013-03-15 | |
| 2011-09-30 | $5.03M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $5.50M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $7.32M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |